| 01/11/23 | 07:00:08 | 1 Nov 2023 | | Results for the year ended 30 June 2023 |
| 20/10/23 | 07:00:08 | 20 Oct 2023 | | Notification of Preliminary Results and AGM |
| 11/09/23 | 10:17:47 | 11 Sept 2023 | | Clarification on Press Report |
| 31/08/23 | 15:51:38 | 31 Aug 2023 | | Re-appointment of Independent Director |
| 02/05/23 | 07:00:09 | 2 May 2023 | | Q3 Financial Results |
| 11/04/23 | 15:59:45 | 11 Apr 2023 | | Holdings in Company |
| 31/03/23 | 11:03:08 | 31 Mar 2023 | | Holdings in Company |
| 30/01/23 | 07:00:03 | 30 Jan 2023 | | Half Year Results 2022-23 |
| 19/01/23 | 07:00:08 | 19 Jan 2023 | | Payment of Cash Dividend |
| 23/12/22 | 07:00:02 | 23 Dec 2022 | | Annual General Meeting Statement |
| 29/11/22 | 14:06:11 | 29 Nov 2022 | | Second Price Monitoring Extn |
| 29/11/22 | 14:00:43 | 29 Nov 2022 | | Price Monitoring Extension |
| 16/11/22 | 07:00:07 | 16 Nov 2022 | | AGM Notification |
| 11/11/22 | 07:00:05 | 11 Nov 2022 | | Financial Results for the First Quarter |
| 08/11/22 | 07:00:06 | 8 Nov 2022 | | Results for the 12-month period ended 30 June 2022 |
| 28/10/22 | 07:00:07 | 28 Oct 2022 | | Notification of Preliminary Results and AGM |
| 28/04/22 | 07:00:07 | 28 Apr 2022 | | Q3 Financial Results |
| 01/04/22 | 07:00:08 | 1 Apr 2022 | | Sanofi Bangladesh Ltd. renamed Synovia Pharma PLC |
| 17/03/22 | 14:30:08 | 17 Mar 2022 | | MPP sub-license for Pfizer’s COVID-19 treatment |
| 28/01/22 | 07:00:07 | 28 Jan 2022 | | Half Year Results 2021-22 |
| 21/01/22 | 07:00:12 | 21 Jan 2022 | | Payment of Cash Dividend |
| 20/01/22 | 09:00:10 | 20 Jan 2022 | | License to produce molnupiravir for COVID-19 |
| 30/12/21 | 10:38:00 | 30 Dec 2021 | | World's first generic version of Pfizer’s Paxlovid |
| 24/12/21 | 07:00:02 | 24 Dec 2021 | | Annual General Meeting Statement |
| 08/12/21 | 07:00:07 | 8 Dec 2021 | | Delivery of COVID-19 vaccine doses |
| 02/12/21 | 07:00:05 | 2 Dec 2021 | | Update on the supply of COVID-19 vaccine |
| 24/11/21 | 07:43:37 | 24 Nov 2021 | | Statement re: media comment |
| 16/11/21 | 07:00:12 | 16 Nov 2021 | | Notice of AGM |
| 11/11/21 | 10:30:00 | 11 Nov 2021 | | Results for First Quarter Ended 30 September 2021 |
| 09/11/21 | 07:00:03 | 9 Nov 2021 | | Launch of world’s first generic molnupiravir |
| 02/11/21 | 07:00:02 | 2 Nov 2021 | | Results for the year ended 30 June 2021 |
| 21/10/21 | 12:36:36 | 21 Oct 2021 | | Notification of Preliminary Results and AGM |
| 11/10/21 | 07:00:10 | 11 Oct 2021 | | Update on the supply of COVID-19 vaccine |
| 01/10/21 | 07:00:06 | 1 Oct 2021 | | Completion of Sanofi Bangladesh Acquisition |
| 14/09/21 | 10:20:02 | 14 Sept 2021 | | Sanofi Bangladesh Share Purchase Agreement signed |
| 03/09/21 | 13:10:18 | 3 Sept 2021 | | Acquisition Approved by Bangladesh Bank |
| 25/08/21 | 18:01:13 | 25 Aug 2021 | | Statement re: media comment |
